N
Google TrendJONAS BROTHERS (500+) — Jonas Brothers postpone Birmingham concert over weather concerns
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:jonas brothers500+steven kwan500+kings vs warriors200+steffi graf200+boxing200+ben simmons500+lisa500+bill maher500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Clinical Trial to Evaluat" (30 stories)

Top Headline Story

Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies
Lead StoryLife Biosciencesscience
1d ago

Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxPRkx3b3F0dDd5Vlh6NFpkMkk0WVZmUUJLR1dtaDdGVzRNdHZuSm0xRTUzaWRaY0xiVUoydzcyVzl3ZE5VblVQWjZJd0ZweXJ5UGxFYy1fRmMyeW9WWGUtUGUxT1pzVFF5Zy1YUzJiN1ozeW1fZ0djV0o3UTU1R19hWTFaRGlkVUQteDI2dzVKVnp5VlVNTWRWUGk4VEdLclpvTWgwSGhvZHBjQmxtaWtzcFB1ekttdFh4T2s3QkF4Q0F2UklDYUdvNVRwbEk1cWE2Rm5PVjU5QlVQcHBHNkJr?oc=5" target="_blank">Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies</a>  <font color="#6f6f6f">Life Biosciences</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+21m ago

jonas brothers

Jonas Brothers postpone Birmingham concert over weather concerns

Filter stories
500+21m ago

steven kwan

Guardians' Steven Kwan Could Shake Up Winter Outfield Market

Filter stories
200+21m ago

kings vs warriors

3 Storylines I'm Focused On in Warriors Preseason Game vs. Kings

Filter stories
200+21m ago

steffi graf

PICTURES: Steffi Graf & Daughter Jaz Feature In Andre Agassi’s ‘Photo Dump’ As Carlos Alcaraz & Karl-Anthony Towns Make Surprise Appearance

Filter stories

Search Results for "Clinical Trial to Evaluat"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
Business Wiretech

Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway

<a href="https://news.google.com/rss/articles/CBMixgJBVV95cUxNZ255bkFQdTg4Qkdtc25faThKRkNJczEyUUhINWNlY3dydzViSXEtbVRUbjU2dFdESU1YdWJYWVVDWjF3V2hjNWtxQy1iOF9tRkQ5X1diRHFVVFFvYXVlclhqSWVZamJxaU1RaXJjLS1yTzVTdnNIdkkxbXc3MTk2aWdKRXpJUzFYdlNYZXNaQWRGQUxBOFMzc2trQWJhcGtZbzhEeVI5QWV4VFlZNHIwTmZDU2F4cG5rV2VTTmpvTk1UMmpfNWRiNUhHTlVpMTgwRU14Y1p2U3lKeDJEOUduYzBRdHZyTy1vM3BESDBIQW0ydVI2MDBackt6RkxJRGFnbnFnQ2RzcnpwNUg3TUo4QXhaNFFWOENxa2s1NkIyWGROcnR4OUtfTHhDdWt5T3VNWFZ6VGxMSDJablZNRU1sUlFSTHc1Zw?oc=5" target="_blank">Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Clinical Trial to Evaluate Safer CAR T-Cell Therapy for Children
Research Horizonsgeneral

Clinical Trial to Evaluate Safer CAR T-Cell Therapy for Children

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPWEkwdTZoX1lUNnBmd0Zpd0dLWVhldzFxUUV1bGRWV09Bc01Ub3RPeFV5Z3RDblhvbFNjajByX2xNMlpVd3ZRTm5oeExuTUpNLUwzNnY1aFFlN3M1VENBVm1pV0piUVpwakFBM0pJN3hvVkJoa0ZpOFRTZFlOSUtnb25LMzZKTXM0NWZyamRUbjZWRk4tdXNHaWxWWnBldjdqMlZVVWlha05mc2xSeUE?oc=5" target="_blank">Clinical Trial to Evaluate Safer CAR T-Cell Therapy for Children</a>  <font color="#6f6f6f">Research Horizons</font>

Read Full StoryMore like this
Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records
Naturetech

Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5UQTAyRXJsckQ0dDlaa0FiUHFLNE16NXNWa3VXNUtGM1N2alN1MGdhMV9wdlRnZm9XaktxUXhDc3V6YlJQdzJDaE9Cb0hZMl8xSWhKdEdnMy1nSFRTOFJB?oc=5" target="_blank">Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Evaluating AI-Enabled Trial Screening in Real-World Oncology Workflows
Regenstrief Institutetech

Evaluating AI-Enabled Trial Screening in Real-World Oncology Workflows

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTFB5VmVJT0tSWEZERF8xY09rWXI0VkVEN3JCdlpzSEJIRDZFd0p1LUt0bGlTMHc1MWhvdlJPa1hubGRIaXZqcFVqa0NzdTVlQS1EOEIwZUJLMi12cTNYZzdRLXlvcTVnX0ZzQXNPRHNNTWg0Wkhr?oc=5" target="_blank">Evaluating AI-Enabled Trial Screening in Real-World Oncology Workflows</a>  <font color="#6f6f6f">Regenstrief Institute</font>

Read Full StoryMore like this
June 16, 2026: LungSMART Team Uses Bilingual Formative Evaluation to Hone Study's Digital Health Content
Rethinking Clinical Trialsscience

June 16, 2026: LungSMART Team Uses Bilingual Formative Evaluation to Hone Study's Digital Health Content

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPQnJ3UU1ZYTFFdG45d2s0bGZYbW9nTHhZTWZXbTBlVTMxVVNLOW1jT1VQbC1VWS1mNl80bkVBM2hETXEtcE9CYXNiQ09aNF9PcmV1UkhlcFhQOXNIYW9tRkZ6Z0wwaFlib3ZmVDNCZDhLa0F6RE43R2pETmdXTklfSUVVTHNOOUgzRGd6Smt2TUl4OENaMDR3dGtvSU80dExOa25FWmdNeDVuRUxEbXBlODQ1V0RsQ2FqVFpHSWhKTDBxaGJXTEw3SDgtbWtreHBEU0pKWF9ySWZqaDF4?oc=5" target="_blank">June 16, 2026: LungSMART Team Uses Bilingual Formative Evaluation to Hone Study's Digital Health Content</a>  <font color="#6f6f6f">Rethinking Clinical Trials</font>

Read Full StoryMore like this
A Digital Twin of RAS Wildtype Metastatic Colorectal Cancer to Evaluate the Efficacy of Standard-of-Care
Applied Clinical Trialsgeneral

A Digital Twin of RAS Wildtype Metastatic Colorectal Cancer to Evaluate the Efficacy of Standard-of-Care

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOMGZBd1JoRHBDODlaVVVwZWtJbXdMUXFuOG1NMHZWSzdXdDJVbnRId2xXR09NV1YzTGFleXF2M1VlT0xObFRnWkxfZjBQTkw2QTNDUHVUUTVFTl9kTnhpeHZ4ZlJYaThlMVNOMzd4aGtkSTc1aE9fM2pnSHpkRHlSbzc1clpRMWRoQWtHOExuV0pJTVpHNnI3dm9BYTRVVm5VWG96MkZzU25yMVNsck5WVzZzWDRCcmVSVEJwbTgtc1I4YTR3VnZQWlpqTmU5UTFy?oc=5" target="_blank">A Digital Twin of RAS Wildtype Metastatic Colorectal Cancer to Evaluate the Efficacy of Standard-of-Care</a>  <font color="#6f6f6f">Applied Clinical Trials</font>

Read Full StoryMore like this
Marshall Health Network enrolling patients in lung cancer clinical trial evaluating personalized immunotherapy approach
Marshall Healthscience

Marshall Health Network enrolling patients in lung cancer clinical trial evaluating personalized immunotherapy approach

<a href="https://news.google.com/rss/articles/CBMi9gFBVV95cUxNNzdxc1hNTFRPcTVFYUx0TGdvbHg2VE5rRE5mTzdtc2puWWhweXY0UmtmVi1uMGZEdkt0cFh4RHREVHNadFppMFZBX0Y5S1RwZGRaQ1liZmRpMS04aU90QUYzQndQcjJKalZ3Tk5DZVd1Vm5LbFZHSDNIUkVjUjdIUzJ1RFlnendxTkN2OUQwT0FRWmpudjh5UHp5aHJLdXlfR01Wd18tMW83VWtYd0NSLUJRY1VxVXlyVDFWT0lBQm1PRFZHcUpQMGpsQ2g5TnI2R2ZBU2xRczg5TjBnWE9OQVNYQlRmTWl5X1VKa19NeDd4S1F5bmc?oc=5" target="_blank">Marshall Health Network enrolling patients in lung cancer clinical trial evaluating personalized immunotherapy approach</a>  <font color="#6f6f6f">Marshall Health</font>

Read Full StoryMore like this
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
GlobeNewswireworld

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

<a href="https://news.google.com/rss/articles/CBMilAJBVV95cUxNcDd5UGQwOWp0dF9kQ3RtZVNpUzZNTXVWZFFtZVZCbFQzQ0NpWEt0MXdWWDdLX05QNW1OTDNWUVo4VWgtT3hRTjJoaDlNZ05zM1Bwc3RXNEh5RVN0aHdjVVpQMktSeEhZSHNKUkFsSXM1M1JnQ0taU3Z5V0xhVHpZNjVGNURJX01uTW94RVhKUE0yZUQ4eUh5dzcyVU9hUU1qbzZwMmZzTmRtWDd6bnNYV1ViUEYxM2FkMUNBOExOUG85TVowbV9Bc1MwVWp4U2syeWFPZHhVbXVuTTFBbl9iX0pibXlRaTdRYThBQlRuY1N6X2stRXdJbE1lRGFvQWgtbkNQSlY4M3otWnlEY2tDajF4Qzc?oc=5" target="_blank">Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
Yahoo Financescience

Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPLUVvem5mVC12bFBlQkUtWVVQcm9FQzNwTkgyWUM5UllESkY1elRFVG5kV09jVkxDV1Q1MTA1eHU3X0JDNTN0am5ZZDd5V2RSWDZVRTVBV1ZNZjlZcUdTX21seHZLYnUwVjN1WGdwSkFIYS1WZ3A3RXJzVHltaG55Z3JiVlBRWllVNll6Nl9UWEtmdGI4VGc?oc=5" target="_blank">Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)
TG Therapeuticsworld

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQaTB2cDBrVzNfOFpnWDBRZzNjdUtieTRLdndtSTA4dkVyOTlpRVFnN3FmeVNCUlU0dmlWRkpXem83S0M1bDVjN3p5ZWtfd2FkWlZKZHM2aVVkYmNia3d0dy00aVdmeE9YTE1YclNFU1lXRkdrQUxsN1JmdXlibUZoeXctcGYxX3JPOWJ5LUktSVNRUU01YnYyS3hieEE3U2NkaERscFdJaldfTk1YVlBHa3ZFWmJINjZWeWowQ1l3?oc=5" target="_blank">TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)</a>  <font color="#6f6f6f">TG Therapeutics</font>

Read Full StoryMore like this
Accelerating Rare disease Cures (ARC) Program
U.S. Food and Drug Administration (.gov)general

Accelerating Rare disease Cures (ARC) Program

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxORGpFTUctajRlZVM0OUE0T1BQakxXYVh2Q2N3ZHZhLUt4Z2F5Q3lPc1lvUi1RU3VoNGd4YTN0bVhMRG5TdXowSWh1dUxBUXE5aEhOdW5oVld2TU1ZN29ndW1VWnBuV2Z5bDZBVE8tRFNaMDduVUtGcnRfWThYQ2duX2Y0X3JQeG91VGFxaUZ1NFR0NmtNZnJ3b2loRFN3UUUtdC13XzBmQzBNS0lRUHNteVhtTl8?oc=5" target="_blank">Accelerating Rare disease Cures (ARC) Program</a>  <font color="#6f6f6f">U.S. Food and Drug Administration (.gov)</font>

Read Full StoryMore like this
Physiotherapist-led care for musculoskeletal conditions in the emergency department (RESHAP-ED): a randomised controlled trial with economic evaluation
The Lancetgeneral

Physiotherapist-led care for musculoskeletal conditions in the emergency department (RESHAP-ED): a randomised controlled trial with economic evaluation

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQaGw1ZHMyMWJydktCejYyZm5ZV3ZjWXdvR1dnR0tLOXJybEJrcU1VMjRwbEhHcDVTMHRrY1RRejlDbUFBNFkybEU1eUVyS0EwOU1zX0tOVlkyZWpSUTVrYnlhcFhoeHdDSzVvNnpzb196dGQ0N1FlNm9mNHpIMFZIRmZuNS1yYmRlMWhZ?oc=5" target="_blank">Physiotherapist-led care for musculoskeletal conditions in the emergency department (RESHAP-ED): a randomised controlled trial with economic evaluation</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
Phase 3 EPIC Trial to Evaluate NRTX-1001 Cell Therapy in Drug-Resistant Mesial Temporal Lobe Epilepsy
NeurologyLivegeneral

Phase 3 EPIC Trial to Evaluate NRTX-1001 Cell Therapy in Drug-Resistant Mesial Temporal Lobe Epilepsy

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNMmVCQlAzZmZpa0t6cmRZZUhnSHFJb0hiN1JqMHlaUDRfSS1Oek1OVDEyNWRuN0NUb0pnR0dELUZrWnZVUmxQY2pGNERfbTFVM0NzQ2RxWWZDN205dXNQVmc4SUhiWHhfM1h1YU1nbkJfS1RfWDMyUkJIUGYyS2NPQXVHdWJoVUZZRnlGT2VEZWdpdXk1MkVkYTNad0lxUnpQdmJFNTRmOG5fOGY2OUh3R2s5cy1NN3JxU3V0a0pJblAzS3ExbGxIbFBn?oc=5" target="_blank">Phase 3 EPIC Trial to Evaluate NRTX-1001 Cell Therapy in Drug-Resistant Mesial Temporal Lobe Epilepsy</a>  <font color="#6f6f6f">NeurologyLive</font>

Read Full StoryMore like this
Evaluating clinical trial eligibility criteria: recruitment methods, informed consent, control and blinding
The Pharmaceutical Journalgeneral

Evaluating clinical trial eligibility criteria: recruitment methods, informed consent, control and blinding

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxONFlZY3BWMzBNWUIyNVVQNEpsOVpOSHE3TE5VOThuOFBra2xGQWFNdkZoYkd6ZWZhdERsT1YzdUxKVXBZX20xdmxvRHBSY0pXRmxxTngzWXhuYjVWajNhMVF0SUg4NWF6dWFJSlp5cW5LdUYzakdrYmdEUks5UTVIVzdwWVBWZHExakVUenNtZGxCWmNSQTMwNTNoYzRGUjFXblQ0QzhGM2RmUlk0V2JLcklIVWxGUDhVVU5jSU1KUmZmcEF6NThKdnNZWTJweWROZ1dnbzBnMURPdklEcjRBRmdqRmU?oc=5" target="_blank">Evaluating clinical trial eligibility criteria: recruitment methods, informed consent, control and blinding</a>  <font color="#6f6f6f">The Pharmaceutical Journal</font>

Read Full StoryMore like this
Evaluation of surgical stress after colorectal interventions: a multicenter randomized clinical trial of robotic versus laparoscopic surgery
Naturegeneral

Evaluation of surgical stress after colorectal interventions: a multicenter randomized clinical trial of robotic versus laparoscopic surgery

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB3MGY1UU5FY0hSZjBFRXE1ci1FRHF3ekJaN1JtQ055X2o2cndQdE5NOV84NEtFSG5QcXJva3dvWE00Q2NjMHJfLUhSV3FYTGhSQVg4Y1htMnU4Z2dLVkhN?oc=5" target="_blank">Evaluation of surgical stress after colorectal interventions: a multicenter randomized clinical trial of robotic versus laparoscopic surgery</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma
Business Wireworld

Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma

<a href="https://news.google.com/rss/articles/CBMisAJBVV95cUxOdFlsR3gtMXpvVTY4YnlZOUtHYkpKZzJNaDl3Zncta0drNU8weko4cWtJaWxDMXFfczlqdEtHRFk1STBVamZ5WkJaMjUyb0llZDlsbGxteXF0ZXBpT1lpMzdWajdHNlBjZ3VrZGd2eHVGY1E5bFhPWlA3TEJRbHhJQmpKZnBHWmpEcDdMTkJDVVI1Sk1SZnZhczUzQzZ0OXptcUx6M0dYLXN2U3JGaVZCbFc2MHlWdEZ3NmM1dVRFdTdmMlN0U2FiTlRaMlNGNGVWbk5RUG5PTklPMzlFX1c4X2pWelc2bFlHN25zdHg0Z0Z0ck1ybFpuNTNFR2NaZ3p4RHJUbkVWVEJreTdwVmRlTXBQMllvbmFNU09HMmliYTMyUzV6RDcxeU9vNHFTMnBj?oc=5" target="_blank">Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
TG Therapeuticsworld

TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNbE9obFdLRl9QQjFEQTA0bGs5N0c0a2RZMks0clRGUFVLbTNQcVJCRHdvM2c2VUZZUjNxNGZpUm9jYWMtS25pbG9MQnQwdmJLTEhwcWR5blN1NmFNY2lZZkwzVU4xVDdMb3JZeEFmSkpRaTR6dEE2NE5UdmFxRTJZZ3RSanpla21YNW5vTGlBdzY3VkdwMktjeGVGVTRoTUttV0xkZXltZzgwMElKc19TeHZrUzlESmpRYkdWN0xkU0liZ0Zn?oc=5" target="_blank">TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia</a>  <font color="#6f6f6f">TG Therapeutics</font>

Read Full StoryMore like this
Prospective evaluation of genomics-guided off-label treatment
Naturegeneral

Prospective evaluation of genomics-guided off-label treatment

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1jekl2RHg4eDlmZEJvckNNV1c0a1NnTEhCYXJOWWFDYlFBdXV0dTk0T3Ffb1pqdkhGZXVLLVItRy1QamJzcjJTTmQwLWduLTBONFlaVFdhZlpHZ1l6ZVRj?oc=5" target="_blank">Prospective evaluation of genomics-guided off-label treatment</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Comparative evaluation of anesthetic delivery systems on pain, anxiety, and physiological responses in pediatric dental patients: A randomized clinical trial
Naturetech

Comparative evaluation of anesthetic delivery systems on pain, anxiety, and physiological responses in pediatric dental patients: A randomized clinical trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE04ODE0OFJpNkpQaGUtaHlQOHVWamhtcVNKcVRmdU9jRWRSMGhxRnZGa1EyS0dFcDZYNWtNdmtnMmJJQjVTNWgySjNLeXJhcDV0XzhTVVhaYjVaVVg3NUgw?oc=5" target="_blank">Comparative evaluation of anesthetic delivery systems on pain, anxiety, and physiological responses in pediatric dental patients: A randomized clinical trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
June 10, 2026: Evaluating Treatments for Fatigue in Patients With Long COVID, in This Week's Rethinking Clinical Trials Grand Rounds
Rethinking Clinical Trialsworld

June 10, 2026: Evaluating Treatments for Fatigue in Patients With Long COVID, in This Week's Rethinking Clinical Trials Grand Rounds

<a href="https://news.google.com/rss/articles/CBMigAJBVV95cUxQQ01WeFk3cUtDTDlhZ3hEajBYc1JXSUVUVGJQWlJ0bHB6NU5XYkZUa3Iza2ptRzZEaElUNW11dkI0SlA2Nm05UHFhZ1VfSVBoUTYxbXVfVzZ3Ui15eGMxNHkzSkFiV2NTSEZna0NST3AzNXJ4eW1reVFWSXE4cVNNSXpzSGhBdVFVeEFqMUNYd0lvWkNZcGRrTXZwdjdPTDJGRzlEcmg2ZUJkMUVtd0FoQUNKaE5RVDRuR0hrRjhBWW13RWEyZFREelBzYkxPSUxBYUh4V09rYlROT0EzWjRrLTdKZ2tubEx4NEVHYXBncEQ5aFlkUTRqbzhwSGtuZUJB?oc=5" target="_blank">June 10, 2026: Evaluating Treatments for Fatigue in Patients With Long COVID, in This Week's Rethinking Clinical Trials Grand Rounds</a>  <font color="#6f6f6f">Rethinking Clinical Trials</font>

Read Full StoryMore like this
Managing emotional distress in older adults with mental illness: a randomized controlled trial evaluating virtual reality relaxation
Naturegeneral

Managing emotional distress in older adults with mental illness: a randomized controlled trial evaluating virtual reality relaxation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1wZEp6UFhySXQ1VE8zSXE4Z0xuRjN5N0R2Sm9RLW4yc1YxMWNTdll2TDk2MDRQbnNaWDFMc2lldjJWM2loZXI5SDNUNlpGZVhFSnAzTFFINmx6LS15VXJZ?oc=5" target="_blank">Managing emotional distress in older adults with mental illness: a randomized controlled trial evaluating virtual reality relaxation</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs
Infection Control Todaygeneral

Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNZ3NiZm1CV09OOXNocTA3dmdRWC1SODdiOTBTVkloUTBkbzlyODZBZlprNzI0bkg3MXJtSkJIUmwzLS1rcFNHdU9TUlVLbER1VWdpaUM5VHA3QnQwQ2RVTnpmcE9hTFJINkVrRUNtSG5haHZjZlgwWjRGVVliZjdfUlY0MTAxSHRyNDNRcFdtNGtLdk9DR0ZTZy1NSkJRSW0yUE9PWDlXWWZGbXRYanZGYy0yNE9VRFRNM3Rr?oc=5" target="_blank">Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs</a>  <font color="#6f6f6f">Infection Control Today</font>

Read Full StoryMore like this
RecovryAI Completes Patient Phase of Pivotal Trial Evaluating Its Clinical AI in Advance of FDA De Novo Filing
Business Wiretech

RecovryAI Completes Patient Phase of Pivotal Trial Evaluating Its Clinical AI in Advance of FDA De Novo Filing

<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxPamthRzUtSllqU05UQ3VsTm9CMG1WSWlLU0U4QzRwbkpsZEw4cHFfOVJwZ1dJTUlwWUhGLVNVUWE5eGU4VW9ZQlJJZmhlT3JZeDkwemNwempjbFI2R0ZxeFBMVDlOSjhhRVZ0b3AzbE9VSjFNeFV6T2pWOEh6RHlUUUFVM0hVM2dIOC1LQVNLU0g1U0swS2lmXzcwdy1ZeWJac2Rpb0hBUWZ0ODZ3aVZGRDJGaXJ4Rl83ZGdneUpfRmJ0bFBTdEltWG9iWkxNdG9FbUZHc2lBWnV6RXg2ZWpUZ05CX1hEUFluRDV2NDY5a2xVamtXRnhlY3VJOA?oc=5" target="_blank">RecovryAI Completes Patient Phase of Pivotal Trial Evaluating Its Clinical AI in Advance of FDA De Novo Filing</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
Business Wirescience

Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer

<a href="https://news.google.com/rss/articles/CBMirAJBVV95cUxQZk82c3FNSVZEamtFM21IeFVmZ1lhWEV5UjAzUlltNmR1TTdDTFJIa0l2RHhKSzBfRFViRnBQeWxLbGxld3B5MExEVHl0SlpzQmp6V3V2VldGX3ZUNF83aWhOd1l1SVZ1N29RUTJwbVppNFBHZ3dHYnlaUEV4enQ2c3hiVlJ4WFBEWWZUNWZrMHliU2hnZk1pRm5wNHVHV2hKQ28yMGRxTFVCVVpLSDZJM2RKYnhsQUhwU2p6WTU2Z2pmN05BdGFqb0lGT3FUOHpvWjFIb2ZwX2Z5Q3hjS0QzRzhuWVo4ZUJ6dU1hb3hFX2VHNUt6Q1dKY1gtZmZOUzV3azl6N0I5bEswVjVlRzJjc2pzcFdONVViZW5FeXRVT0xGc0h0SUhQOFplQUE?oc=5" target="_blank">Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Evaluation of clinical impact of ultra fast-track... : European Journal of Anaesthesiology
Ovidworld

Evaluation of clinical impact of ultra fast-track... : European Journal of Anaesthesiology

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNSFUwblF5T1pYYXFsZlY1NnFTejdjam5oaTdSbDdTcnFXT2prVGdVY1VTNWp0X20yRmpYTXZuSktHREJHeVhrUEhDVzdtSTVrckhOSGtDZ0VOZlBXYVhwUnQ3bmI0X0xOdG92ZFl2cGh0TFNKREZGUGxUVnEycS0wTzBQeXowTzZ6RXFGbkNSTlpIdksyZVMzS3pSbE5iLThSR3R3d0FzNVFGemEtM3p5ekVFWDZvdzdTLTRhX050M1kwNjJURG9MZjhGbVhJZEJnUDJtaw?oc=5" target="_blank">Evaluation of clinical impact of ultra fast-track... : European Journal of Anaesthesiology</a>  <font color="#6f6f6f">Ovid</font>

Read Full StoryMore like this
Evaluating Treatment Effects with Patient-Response–Related Outcomes in Comparative Clinical Trials
NEJM Evidencegeneral

Evaluating Treatment Effects with Patient-Response–Related Outcomes in Comparative Clinical Trials

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE9jbEhidzFORzFobUp0SDlwenN3UkdjcWVuaVhMX2Fhcmw4SjlpRllLS05uVER3TFZ2cjJXc2JwZk1VLUEzdzlEeF9LWjZxZnZaOWw0dFFXQWhVcS1LUG00VV8tZmpTZkFu?oc=5" target="_blank">Evaluating Treatment Effects with Patient-Response–Related Outcomes in Comparative Clinical Trials</a>  <font color="#6f6f6f">NEJM Evidence</font>

Read Full StoryMore like this
Multidisciplinary blinded randomized expert evaluation of large language models for clinical diagnosis and management
Naturegeneral

Multidisciplinary blinded randomized expert evaluation of large language models for clinical diagnosis and management

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5IbmlQWnN1TGdtRGd3ZFRqMFRCNkphN2ItWHhVSGpXWnRkc01YWndjekRsTzhoVEEzVVNQOTc3WFNZb01SbzlXMjc3TVdNM2owR2s3REtXZ0o1VlZtMTBV?oc=5" target="_blank">Multidisciplinary blinded randomized expert evaluation of large language models for clinical diagnosis and management</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
CDER’s Framework for Regulatory Advanced Manufacturing Evaluation (FRA
U.S. Food and Drug Administration (.gov)general

CDER’s Framework for Regulatory Advanced Manufacturing Evaluation (FRA

<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQZmVLZGhucGZ1bnpVcGtQWTRYX1ZucW1RZ2lySlAzVGdDV25saTVwd3dYWXdNLXhZZjBRMVdjTzVOYm1XcTVIUjBwVks1TnN3ek5TM2R6MURsTW5kTmpMb1YxR3EzaUxKQW5ENzBCcE10Y2VWb2ZWQTh6aG83R21CWU1xVUt3UWNUdTJSS05tcHc1Rk9EakhhVF9Zbk5MTHNpLWRkSXNycFczVE14MW55amczbUdYY1lBQVBxWjZqbk9qM1I0RnJyMTUxeWRnazBRaGhCTFFXZWVWaFRtRDBiYzBB?oc=5" target="_blank">CDER’s Framework for Regulatory Advanced Manufacturing Evaluation (FRA</a>  <font color="#6f6f6f">U.S. Food and Drug Administration (.gov)</font>

Read Full StoryMore like this
Evaluating Noninferiority in Clinical Trials with a Hierarchical End Point
NEJM Evidencegeneral

Evaluating Noninferiority in Clinical Trials with a Hierarchical End Point

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE5aU3E2eElIU2poZVpzTzZHQ1lhbkRoVHZoa2ZaVkhvM1BlTUJDUW11WmhJN2VfQzdCSUFhQ01vaW5aTzR4ZkJuZFp5ckV0blFHcWEtM1pIdmtaMS1nenhqMWItUU52NzB6?oc=5" target="_blank">Evaluating Noninferiority in Clinical Trials with a Hierarchical End Point</a>  <font color="#6f6f6f">NEJM Evidence</font>

Read Full StoryMore like this
"Clinical Trial to Evaluat" — Live Google News Trends & Headlines